Delaware |
000-52607 |
98-0424072 | ||
(State or Other Jurisdiction
of Incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) | ||
1 Corporate Avenue
Rowville, 3178, Victoria
Australia |
Not Applicable | |||
(Address of Principal Executive Offices) |
(Zip Code) |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
| |
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
| |
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
| |
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class |
Trading
Symbol(s) |
Name of each exchange
on which registered | ||
Proposal No. |
Proposal |
VotesFor |
VotesAgainst |
Abstentions | ||||
Proposal 1
|
Issue of Underwriter Options
|
54,705,830
|
153,223
|
28,624,984
|
UNIVERSAL BIOSENSORS, INC. | ||
Date: May 23, 2022
|
By:
|
/s/ Salesh Balak
|
Salesh Balak
| ||
Principal Financial Officer
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Universal Biosensors Inc. published this content on 25 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2022 16:11:54 UTC.